Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update on License and Collaboration Agreement with Neurocrine Biosciences
To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 3665957. The audio webcast will also be broadcast live on the “Investors” section of Xenon's website at www.xenon-pharma.com and available for replay following the call for 30 days.
About
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of
Investor/Media Contact:
Phone: 604.484.3353
Email: investors@xenon-pharma.com
Source: Xenon Pharmaceuticals Inc.